{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T04:17:56Z","timestamp":1791001076072,"version":"4.1.0"},"reference-count":68,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2020,8,13]],"date-time":"2020-08-13T00:00:00Z","timestamp":1597276800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,8,13]],"date-time":"2020-08-13T00:00:00Z","timestamp":1597276800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/501100001775","name":"University of Technology Sydney","doi-asserted-by":"publisher","award":["Start-up Research Fund 2018"],"award-info":[{"award-number":["Start-up Research Fund 2018"]}],"id":[{"id":"10.13039\/501100001775","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Mol Neurosci"],"published-print":{"date-parts":[[2021,3]]},"DOI":"10.1007\/s12031-020-01678-6","type":"journal-article","created":{"date-parts":[[2020,8,13]],"date-time":"2020-08-13T10:03:55Z","timestamp":1597313035000},"page":"565-582","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":13,"title":["Robust Dopaminergic Differentiation and Enhanced LPS-Induced Neuroinflammatory Response in Serum-Deprived Human SH-SY5Y Cells: Implication for Parkinson\u2019s Disease"],"prefix":"10.1007","volume":"71","author":[{"given":"Aram","family":"Niaz","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jocelyn","family":"Karunia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mawj","family":"Mandwie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kevin A.","family":"Keay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giuseppe","family":"Musumeci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ghaith","family":"Al-Badri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7037-759X","authenticated-orcid":false,"given":"Alessandro","family":"Castorina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,8,13]]},"reference":[{"key":"1678_CR1","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1111\/ane.12590","volume":"135","author":"AD Andersen","year":"2017","unstructured":"Andersen AD, Binzer M, Stenager E, Gramsbergen JB (2017) Cerebrospinal fluid biomarkers for Parkinson\u2019s disease\u2013a systematic review. Acta Neurol Scand 135:34\u201356","journal-title":"Acta Neurol Scand"},{"key":"1678_CR2","doi-asserted-by":"crossref","first-page":"1683","DOI":"10.1096\/fj.05-5225fje","volume":"20","author":"K Aquilano","year":"2006","unstructured":"Aquilano K, Vigilanza P, Rotilio G, Ciriolo MR (2006) Mitochondrial damage due to SOD1 deficiency in SH-SY5Y neuroblastoma cells: a rationale for the redundancy of SOD1. FASEB J 20:1683\u20131685","journal-title":"FASEB J"},{"key":"1678_CR3","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.1023\/B:NEUR.0000021903.24849.6c","volume":"32","author":"O Avwenagha","year":"2003","unstructured":"Avwenagha O, Campbell G, Bird MM (2003) Distribution of GAP-43, \u03b2-III tubulin and F-actin in developing and regenerating axons and their growth cones in vitro, following neurotrophin treatment. J Neurocytol 32:1077\u20131089","journal-title":"J Neurocytol"},{"key":"1678_CR4","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.biocel.2010.10.016","volume":"43","author":"S Baldelli","year":"2011","unstructured":"Baldelli S, Aquilano K, Rotilio G, Ciriolo MR (2011) Neuronal nitric oxide synthase interacts with Sp1 through the PDZ domain inhibiting Sp1-mediated copper-zinc superoxide dismutase expression. Int J Biochem Cell Biol 43:163\u2013169","journal-title":"Int J Biochem Cell Biol"},{"key":"1678_CR5","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1016\/S0896-6273(00)80597-8","volume":"21","author":"D Baranes","year":"1998","unstructured":"Baranes D, Lederfein D, Huang Y-Y, Chen M, Bailey CH, Kandel ER (1998) Tissue plasminogen activator contributes to the late phase of LTP and to synaptic growth in the hippocampal mossy fiber pathway. Neuron. 21:813\u2013825","journal-title":"Neuron."},{"key":"1678_CR6","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.neuroscience.2006.08.075","volume":"144","author":"S Bennur","year":"2007","unstructured":"Bennur S, Shankaranarayana Rao BS, Pawlak R, Strickland S, McEwen BS, Chattarji S (2007) Stress-induced spine loss in the medial amygdala is mediated by tissue-plasminogen activator. Neuroscience. 144:8\u201316","journal-title":"Neuroscience."},{"key":"1678_CR7","doi-asserted-by":"crossref","first-page":"746","DOI":"10.1007\/s12640-019-00078-y","volume":"36","author":"A Biosa","year":"2019","unstructured":"Biosa A, De Lazzari F, Masato A, Filograna R, Plotegher N, Beltramini M, Bubacco L, Bisaglia M (2019) Superoxide dismutases SOD1 and SOD2 rescue the toxic effect of dopamine-derived products in human SH-SY5Y neuroblastoma cells. Neurotox Res 36:746\u2013755","journal-title":"Neurotox Res"},{"key":"1678_CR8","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1007\/s12640-014-9468-x","volume":"26","author":"D Brown","year":"2014","unstructured":"Brown D, Tamas A, Reglodi D, Tizabi Y (2014) PACAP protects against inflammatory-mediated toxicity in dopaminergic SH-SY5Y cells: implication for Parkinson\u2019s disease. Neurotox Res 26:230\u2013239","journal-title":"Neurotox Res"},{"key":"1678_CR9","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.brainres.2011.05.063","volume":"1404","author":"MJ Brzozowski","year":"2011","unstructured":"Brzozowski MJ, Alcantara SL, Iravani MM, Rose S, Jenner P (2011) The effect of nNOS inhibitors on toxin-induced cell death in dopaminergic cell lines depends on the extent of enzyme expression. Brain Res 1404:21\u201330","journal-title":"Brain Res"},{"key":"1678_CR10","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1016\/j.bcp.2011.11.031","volume":"83","author":"C Bucolo","year":"2012","unstructured":"Bucolo C, Leggio GM, Maltese A, Castorina A, D\u2019gata V, Drago F (2012) Dopamine-(3) receptor modulates intraocular pressure: implications for glaucoma. Biochem Pharmacol 83:680\u2013686","journal-title":"Biochem Pharmacol"},{"key":"1678_CR11","doi-asserted-by":"crossref","first-page":"5899","DOI":"10.1073\/pnas.93.12.5899","volume":"93","author":"TH Bugge","year":"1996","unstructured":"Bugge TH, Flick MJ, Danton MJ, Daugherty CC, Romer J, Dano K, Carmeliet P, Collen D, Degen JL (1996) Urokinase-type plasminogen activator is effective in fibrin clearance in the absence of its receptor or tissue-type plasminogen activator. Proc Natl Acad Sci U S A 93:5899\u20135904","journal-title":"Proc Natl Acad Sci U S A"},{"key":"1678_CR12","doi-asserted-by":"crossref","first-page":"14931","DOI":"10.1523\/JNEUROSCI.3339-11.2011","volume":"31","author":"N Bukhari","year":"2011","unstructured":"Bukhari N, Torres L, Robinson JK, Tsirka SE (2011) Axonal regrowth after spinal cord injury via chondroitinase and the tissue plasminogen activator (tPA)\/plasmin system. J Neurosci 31:14931\u201314943","journal-title":"J Neurosci"},{"key":"1678_CR13","doi-asserted-by":"crossref","first-page":"105734","DOI":"10.1016\/j.intimp.2019.105734","volume":"75","author":"L Cai","year":"2019","unstructured":"Cai L, Tu L, Li T, Yang X, Ren Y, Gu R, Zhang Q, Yao H, Qu X, Wang Q, Tian J (2019) Downregulation of lncRNA UCA1 ameliorates the damage of dopaminergic neurons, reduces oxidative stress and inflammation in Parkinson\u2019s disease through the inhibition of the PI3K\/Akt signaling pathway. Int Immunopharmacol 75:105734","journal-title":"Int Immunopharmacol"},{"key":"1678_CR14","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/j.freeradbiomed.2017.10.379","volume":"115","author":"V Calabrese","year":"2018","unstructured":"Calabrese V, Santoro A, Monti D, Crupi R, Di Paola R, Latteri S, Cuzzocrea S, Zappia M, Giordano J, Calabrese EJ, Franceschi C (2018) Aging and Parkinson\u2019s disease: inflammaging, neuroinflammation and biological remodeling as key factors in pathogenesis. Free Radic Biol Med 115:80\u201391","journal-title":"Free Radic Biol Med"},{"key":"1678_CR15","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1007\/s11064-010-0359-0","volume":"36","author":"A Castorina","year":"2011","unstructured":"Castorina A, Leggio GM, Giunta S, Magro G, Scapagnini G, Drago F, D'Agata V (2011) Neurofibromin and amyloid precursor protein expression in dopamine D3 receptor knock-out mice brains. Neurochem Res 36:426\u2013434","journal-title":"Neurochem Res"},{"key":"1678_CR16","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1016\/j.neuroscience.2013.07.053","volume":"250","author":"A Castorina","year":"2013","unstructured":"Castorina A, D\u2019Amico AG, Scuderi S, Leggio GM, Drago F, D'Agata V (2013) Dopamine D3 receptor deletion increases tissue plasminogen activator (tPA) activity in prefrontal cortex and hippocampus. Neuroscience 250:546\u2013556","journal-title":"Neuroscience"},{"key":"1678_CR17","doi-asserted-by":"crossref","first-page":"e0117799","DOI":"10.1371\/journal.pone.0117799","volume":"10","author":"A Castorina","year":"2015","unstructured":"Castorina A, Waschek JA, Marzagalli R, Cardile V, Drago F (2015) PACAP interacts with PAC1 receptors to induce tissue plasminogen activator (tPA) expression and activity in Schwann cell-like cultures. PLoS One 10:e0117799","journal-title":"PLoS One"},{"key":"1678_CR18","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.npep.2018.12.002","volume":"74","author":"A Castorina","year":"2019","unstructured":"Castorina A, Vogiatzis M, Kang JWM, Keay KA (2019) PACAP and VIP expression in the periaqueductal grey of the rat following sciatic nerve constriction injury. Neuropeptides. 74:60\u201369","journal-title":"Neuropeptides."},{"key":"1678_CR19","doi-asserted-by":"crossref","first-page":"S99","DOI":"10.1016\/S1353-8020(13)70025-7","volume":"20","author":"LM Chahine","year":"2014","unstructured":"Chahine LM, Stern MB, Chen-Plotkin A (2014) Blood-based biomarkers for Parkinson\u2019s disease. Parkinsonism Relat Disord 20:S99\u2013S103","journal-title":"Parkinsonism Relat Disord"},{"key":"1678_CR20","doi-asserted-by":"crossref","first-page":"855","DOI":"10.15252\/msb.20156423","volume":"12","author":"Z Cheng","year":"2016","unstructured":"Cheng Z, Teo G, Krueger S, Rock TM, Koh HW, Choi H, Vogel C (2016) Differential dynamics of the mammalian mRNA and protein expression response to misfolding stress. Mol Syst Biol 12:855","journal-title":"Mol Syst Biol"},{"key":"1678_CR21","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1046\/j.1432-1327.1998.2580123.x","volume":"258","author":"M Costa","year":"1998","unstructured":"Costa M, Shen Y, Maurer F, Medcalf RL (1998) Transcriptional regulation of the tissue-type plasminogen-activator gene in human endothelial cells: identification of nuclear factors that recognise functional elements in the tissue-type plasminogen-activator gene promoter. Eur J Biochem 258:123\u2013131","journal-title":"Eur J Biochem"},{"key":"1678_CR22","doi-asserted-by":"crossref","first-page":"1802","DOI":"10.1002\/glia.20892","volume":"57","author":"O Cunningham","year":"2009","unstructured":"Cunningham O, Campion S, Perry VH, Murray C, Sidenius N, Docagne F, Cunningham C (2009) Microglia and the urokinase plasminogen activator receptor\/uPA system in innate brain inflammation. Glia. 57:1802\u20131814","journal-title":"Glia."},{"key":"1678_CR23","doi-asserted-by":"crossref","first-page":"e0137342","DOI":"10.1371\/journal.pone.0137342","volume":"10","author":"J de Pedro-Cuesta","year":"2015","unstructured":"de Pedro-Cuesta J, R\u00e1bano A, Mart\u00ednez-Mart\u00edn P, Ruiz-Tovar M, Alcalde-Cabero E, Almaz\u00e1n-Isla J, Avellanal F, Calero M (2015) Comparative incidence of conformational, neurodegenerative disorders. PLoS One 10:e0137342","journal-title":"PLoS One"},{"key":"1678_CR24","doi-asserted-by":"crossref","first-page":"2022","DOI":"10.1016\/S0021-9258(19)39934-X","volume":"265","author":"P Feng","year":"1990","unstructured":"Feng P, Ohlsson M, Ny T (1990) The structure of the TATA-less rat tissue-type plasminogen activator gene. Species-specific sequence divergences in the promoter predict differences in regulation of gene expression. J Biol Chem 265:2022\u20132027","journal-title":"J Biol Chem"},{"key":"1678_CR25","doi-asserted-by":"crossref","first-page":"e0136769","DOI":"10.1371\/journal.pone.0136769","volume":"10","author":"R Filograna","year":"2015","unstructured":"Filograna R, Civiero L, Ferrari V, Codolo G, Greggio E, Bubacco L, Beltramini M, Bisaglia M (2015) Analysis of the catecholaminergic phenotype in human SH-SY5Y and BE (2)-M17 neuroblastoma cell lines upon differentiation. PLoS One 10:e0136769","journal-title":"PLoS One"},{"key":"1678_CR26","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1177\/1087057115625190","volume":"21","author":"JI Forster","year":"2016","unstructured":"Forster JI, Koglsberger S, Trefois C, Boyd O, Baumuratov AS, Buck L, Balling R, Antony PM (2016) Characterization of differentiated SH-SY5Y as neuronal screening model reveals increased oxidative vulnerability. J Biomol Screen 21:496\u2013509","journal-title":"J Biomol Screen"},{"key":"1678_CR27","doi-asserted-by":"crossref","first-page":"8983","DOI":"10.1038\/sj.onc.1207115","volume":"22","author":"TF Franke","year":"2003","unstructured":"Franke TF, Hornik CP, Segev L, Shostak GA, Sugimoto C (2003) PI3K\/Akt and apoptosis: size matters. Oncogene. 22:8983\u20138998","journal-title":"Oncogene."},{"key":"1678_CR28","doi-asserted-by":"crossref","unstructured":"Gitler, A.D., Dhillon, P., Shorter, J., 2017. Neurodegenerative disease: models, mechanisms, and a new hope. Vol., eds. The Company of Biologists Ltd.","DOI":"10.1242\/dmm.030205"},{"key":"1678_CR29","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.npep.2009.10.003","volume":"44","author":"S Giunta","year":"2010","unstructured":"Giunta S, Castorina A, Adorno A, Mazzone V, Carnazza ML, D'Agata V (2010) PACAP and VIP affect NF1 expression in rat malignant peripheral nerve sheath tumor (MPNST) cells. Neuropeptides. 44:45\u201351","journal-title":"Neuropeptides."},{"key":"1678_CR30","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1186\/s12974-014-0201-8","volume":"11","author":"H Gonz\u00e1lez","year":"2014","unstructured":"Gonz\u00e1lez H, Pacheco R (2014) T-cell-mediated regulation of neuroinflammation involved in neurodegenerative diseases. J Neuroinflammation 11:201","journal-title":"J Neuroinflammation"},{"key":"1678_CR31","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1186\/1742-2094-10-124","volume":"10","author":"D Gur-Wahnon","year":"2013","unstructured":"Gur-Wahnon D, Mizrachi T, Maaravi-Pinto F-Y, Lourbopoulos A, Grigoriadis N, Brenner T (2013) The plasminogen activator system: involvement in central nervous system inflammation and a potential site for therapeutic intervention. J Neuroinflammation 10:891","journal-title":"J Neuroinflammation"},{"key":"1678_CR32","doi-asserted-by":"crossref","first-page":"S2","DOI":"10.5213\/inj.1632604.302","volume":"20","author":"H Hong","year":"2016","unstructured":"Hong H, Kim BS, Im H-I (2016) Pathophysiological role of neuroinflammation in neurodegenerative diseases and psychiatric disorders. International Neurourology Journal 20:S2","journal-title":"International Neurourology Journal"},{"key":"1678_CR33","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1093\/jb\/mvw009","volume":"159","author":"X Jin","year":"2016","unstructured":"Jin X, Yamashita T (2016) Microglia in central nervous system repair after injury. J Biochem 159:491\u2013496","journal-title":"J Biochem"},{"key":"1678_CR34","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1007\/s12640-019-00132-9","volume":"37","author":"A Justin","year":"2020","unstructured":"Justin A, Mandal S, Prabitha P, Dhivya S, Yuvaraj S, Kabadi P, Sekhar SJ, Sandhya CH, Wadhwani AD, Divakar S, Bharathi JJ, Durai P, Prashantha Kumar BR (2020) Rational design, synthesis, and in vitro neuroprotective evaluation of novel glitazones for PGC-1\u03b1 activation via PPAR-\u03b3: a new therapeutic strategy for neurodegenerative disorders. Neurotox Res 37:508\u2013524","journal-title":"Neurotox Res"},{"key":"1678_CR35","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1016\/j.niox.2006.07.003","volume":"15","author":"R Kavya","year":"2006","unstructured":"Kavya R, Saluja R, Singh S, Dikshit M (2006) Nitric oxide synthase regulation and diversity: implications in Parkinson\u2019s disease. Nitric Oxide 15:280\u2013294","journal-title":"Nitric Oxide"},{"key":"1678_CR36","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1007\/s00204-015-1472-2","volume":"89","author":"EK Kim","year":"2015","unstructured":"Kim EK, Choi EJ (2015) Compromised MAPK signaling in human diseases: an update. Arch Toxicol 89:867\u2013882","journal-title":"Arch Toxicol"},{"key":"1678_CR37","doi-asserted-by":"crossref","unstructured":"Kovalevich, J., Langford, D., 2013. Considerations for the use of SH-SY5Y neuroblastoma cells in neurobiology. In Neuronal cell culture. Vol., ed.^eds. Springer, pp. 9-21","DOI":"10.1007\/978-1-62703-640-5_2"},{"key":"1678_CR38","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1111\/acer.13368","volume":"41","author":"CJ Lawrimore","year":"2017","unstructured":"Lawrimore CJ, Crews FT (2017) Ethanol, TLR3, and TLR4 agonists have unique innate immune responses in neuron-like SH-SY5Y and microglia-like BV2. Alcohol Clin Exp Res 41:939\u2013954","journal-title":"Alcohol Clin Exp Res"},{"key":"1678_CR39","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1124\/jpet.107.125955","volume":"323","author":"YC Lin","year":"2007","unstructured":"Lin YC, Uang HW, Lin RJ, Chen IJ, Lo YC (2007) Neuroprotective effects of glyceryl nonivamide against microglia-like cells and 6-hydroxydopamine-induced neurotoxicity in SH-SY5Y human dopaminergic neuroblastoma cells. J Pharmacol Exp Ther 323:877\u2013887","journal-title":"J Pharmacol Exp Ther"},{"key":"1678_CR40","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1016\/j.cell.2016.03.014","volume":"165","author":"Y Liu","year":"2016","unstructured":"Liu Y, Beyer A, Aebersold R (2016) On the dependency of cellular protein levels on mRNA abundance. Cell. 165:535\u2013550","journal-title":"Cell."},{"key":"1678_CR41","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/j.taap.2007.12.001","volume":"228","author":"YC Lo","year":"2008","unstructured":"Lo YC, Liu Y, Lin YC, Shih YT, Liu CM, Burka LT (2008) Neuronal effects of 4-t-butylcatechol: a model for catechol-containing antioxidants. Toxicol Appl Pharmacol 228:247\u2013255","journal-title":"Toxicol Appl Pharmacol"},{"key":"1678_CR42","doi-asserted-by":"crossref","first-page":"25297","DOI":"10.1074\/jbc.M201869200","volume":"277","author":"G L\u00f3pez-Carballo","year":"2002","unstructured":"L\u00f3pez-Carballo G, Moreno L, Masi\u00e1 S, P\u00e9rez P, Barettino D (2002) Activation of the phosphatidylinositol 3-kinase\/Akt signaling pathway by retinoic acid is required for neural differentiation of SH-SY5Y human neuroblastoma cells. J Biol Chem 277:25297\u201325304","journal-title":"J Biol Chem"},{"key":"1678_CR43","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.brainres.2018.03.022","volume":"1690","author":"X-H Ma","year":"2018","unstructured":"Ma X-H, Duan W-J, Mo Y-S, Chen J-L, Li S, Zhao W, Yang L, Mi S-Q, Mao X-L, Wang H (2018) Neuroprotective effect of paeoniflorin on okadaic acid-induced tau hyperphosphorylation via calpain\/Akt\/GSK-3\u03b2 pathway in SH-SY5Y cells. Brain Res 1690:1\u201311","journal-title":"Brain Res"},{"key":"1678_CR44","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1016\/j.bbadis.2015.10.011","volume":"1862","author":"A Mehra","year":"2016","unstructured":"Mehra A, Ali C, Parcq J, Vivien D, Docagne F (2016) The plasminogen activation system in neuroinflammation. Biochimica et Biophysica Acta (BBA)-Molecular Basis of Disease 1862:395\u2013402","journal-title":"Biochimica et Biophysica Acta (BBA)-Molecular Basis of Disease"},{"key":"1678_CR45","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1160\/TH04-12-0838","volume":"93","author":"JP Melchor","year":"2005","unstructured":"Melchor JP, Strickland S (2005) Tissue plasminogen activator in central nervous system physiology and pathology. Thromb Haemost 93:655\u2013660","journal-title":"Thromb Haemost"},{"key":"1678_CR46","doi-asserted-by":"crossref","first-page":"S40","DOI":"10.1016\/j.metabol.2014.10.030","volume":"64","author":"DB Miller","year":"2015","unstructured":"Miller DB, O\u2019Callaghan JP (2015) Biomarkers of Parkinson\u2019s disease: present and future. Metabolism. 64:S40\u2013S46","journal-title":"Metabolism."},{"key":"1678_CR47","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1111\/j.1471-4159.2007.05018.x","volume":"104","author":"T Monaghan","year":"2008","unstructured":"Monaghan T, Mackenzie C, Plevin R, Lutz E (2008) PACAP-38 induces neuronal differentiation of human SH-SY5Y neuroblastoma cells via cAMP-mediated activation of ERK and p38 MAP kinases 1. J Neurochem 104:74\u201388","journal-title":"J Neurochem"},{"key":"1678_CR48","doi-asserted-by":"crossref","first-page":"253","DOI":"10.3892\/ijmm.2016.2833","volume":"39","author":"N Nakano","year":"2017","unstructured":"Nakano N, Matsuda S, Ichimura M, Minami A, Ogino M, Murai T, Kitagishi Y (2017) PI3K\/AKT signaling mediated by G protein coupled receptors is involved in neurodegenerative Parkinson\u2019s disease (review). Int J Mol Med 39:253\u2013260","journal-title":"Int J Mol Med"},{"key":"1678_CR49","first-page":"266","volume":"13","author":"M Ohlsson","year":"1993","unstructured":"Ohlsson M, Leonardsson G, Jia XC, Feng P, Ny T (1993) Transcriptional regulation of the rat tissue type plasminogen activator gene: localization of DNA elements and nuclear factors mediating constitutive and cyclic AMP-induced expression. Mol Cell Biol 13:266\u2013275","journal-title":"Mol Cell Biol"},{"key":"1678_CR50","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1126\/science.1100135","volume":"306","author":"PT Pang","year":"2004","unstructured":"Pang PT, Teng HK, Zaitsev E, Woo NT, Sakata K, Zhen S, Teng KK, Yung WH, Hempstead BL, Lu B (2004) Cleavage of proBDNF by tPA\/plasmin is essential for long-term hippocampal plasticity. Science. 306:487\u2013491","journal-title":"Science."},{"key":"1678_CR51","doi-asserted-by":"crossref","first-page":"18201","DOI":"10.1073\/pnas.0509232102","volume":"102","author":"R Pawlak","year":"2005","unstructured":"Pawlak R, Rao BS, Melchor JP, Chattarji S, McEwen B, Strickland S (2005) Tissue plasminogen activator and plasminogen mediate stress-induced decline of neuronal and cognitive functions in the mouse hippocampus. Proc Natl Acad Sci U S A 102:18201\u201318206","journal-title":"Proc Natl Acad Sci U S A"},{"key":"1678_CR52","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1002\/glia.22284","volume":"60","author":"D Pineda","year":"2012","unstructured":"Pineda D, Ampurdanes C, Medina MG, Serratosa J, Tusell JM, Saura J, Planas AM, Navarro P (2012) Tissue plasminogen activator induces microglial inflammation via a noncatalytic molecular mechanism involving activation of mitogen-activated protein kinases and Akt signaling pathways and AnnexinA2 and Galectin-1 receptors. Glia. 60:526\u2013540","journal-title":"Glia."},{"key":"1678_CR53","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1007\/BF03033178","volume":"5","author":"SP Presgraves","year":"2003","unstructured":"Presgraves SP, Ahmed T, Borwege S, Joyce JN (2003) Terminally differentiated SH-SY5Y cells provide a model system for studying neuroprotective effects of dopamine agonists. Neurotox Res 5:579\u2013598","journal-title":"Neurotox Res"},{"issue":"Pt 22","key":"1678_CR54","doi-asserted-by":"crossref","first-page":"4007","DOI":"10.1242\/jcs.112.22.4007","volume":"112","author":"AD Rogove","year":"1999","unstructured":"Rogove AD, Siao C, Keyt B, Strickland S, Tsirka SE (1999) Activation of microglia reveals a non-proteolytic cytokine function for tissue plasminogen activator in the central nervous system. J Cell Sci 112(Pt 22):4007\u20134016","journal-title":"J Cell Sci"},{"key":"1678_CR55","doi-asserted-by":"crossref","unstructured":"Rommelspacher, H., 2012. Prospects for new treatment options in neurodegenerative diseases. In Isoquinolines and beta-carbolines as neurotoxins and neuroprotectants. Vol., ed.^eds. Springer, pp. 165-171","DOI":"10.1007\/978-1-4614-1542-8_11"},{"key":"1678_CR56","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1038\/nprot.2008.73","volume":"3","author":"TD Schmittgen","year":"2008","unstructured":"Schmittgen TD, Livak KJ (2008) Analyzing real-time PCR data by the comparative C(T) method. Nat Protoc 3:1101\u20131108","journal-title":"Nat Protoc"},{"key":"1678_CR57","doi-asserted-by":"crossref","first-page":"3234","DOI":"10.1523\/JNEUROSCI.23-08-03234.2003","volume":"23","author":"C-J Siao","year":"2003","unstructured":"Siao C-J, Fernandez SR, Tsirka SE (2003) Cell type-specific roles for tissue plasminogen activator released by neurons or microglia after excitotoxic injury. J Neurosci 23:3234\u20133242","journal-title":"J Neurosci"},{"key":"1678_CR58","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1016\/S0006-291X(02)02453-1","volume":"298","author":"H Son","year":"2002","unstructured":"Son H, Seuk Kim J, Mogg Kim J, Lee SH, Lee YS (2002) Reciprocal actions of NCAM and tPA via a Ras-dependent MAPK activation in rat hippocampal neurons. Biochem Biophys Res Commun 298:262\u2013268","journal-title":"Biochem Biophys Res Commun"},{"key":"1678_CR59","doi-asserted-by":"crossref","first-page":"600","DOI":"10.3109\/10799893.2015.1030412","volume":"35","author":"Y Sun","year":"2015","unstructured":"Sun Y, Liu WZ, Liu T, Feng X, Yang N, Zhou HF (2015) Signaling pathway of MAPK\/ERK in cell proliferation, differentiation, migration, senescence and apoptosis. J Recept Signal Transduct Res 35:600\u2013604","journal-title":"J Recept Signal Transduct Res"},{"key":"1678_CR60","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1038\/nrn.2016.178","volume":"18","author":"DJ Surmeier","year":"2017","unstructured":"Surmeier DJ, Obeso JA, Halliday GM (2017) Selective neuronal vulnerability in Parkinson disease. Nat Rev Neurosci 18:101\u2013113","journal-title":"Nat Rev Neurosci"},{"key":"1678_CR61","doi-asserted-by":"crossref","first-page":"323","DOI":"10.3389\/fncel.2018.00323","volume":"12","author":"Z Szepesi","year":"2018","unstructured":"Szepesi Z, Manouchehrian O, Bachiller S, Deierborg T (2018) Bidirectional microglia-neuron communication in health and disease. Front Cell Neurosci 12:323","journal-title":"Front Cell Neurosci"},{"key":"1678_CR62","doi-asserted-by":"crossref","first-page":"2452","DOI":"10.1007\/s11064-014-1449-1","volume":"39","author":"SS Titze-de-Almeida","year":"2014","unstructured":"Titze-de-Almeida SS, Lustosa CF, Horst CH, Bel ED, Titze-de-Almeida R (2014) Interferon gamma potentiates the injury caused by MPP(+) on SH-SY5Y cells, which is attenuated by the nitric oxide synthases inhibition. Neurochem Res 39:2452\u20132464","journal-title":"Neurochem Res"},{"key":"1678_CR63","first-page":"113","volume":"8","author":"A Tjarnlund-Wolf","year":"2014","unstructured":"Tjarnlund-Wolf A, Hultman K, Blomstrand F, Nilsson M, Medcalf RL, Jern C (2014) Species-specific regulation of t-PA and PAI-1 gene expression in human and rat astrocytes. Gene Regul Syst Bio 8:113\u2013118","journal-title":"Gene Regul Syst Bio"},{"key":"1678_CR64","unstructured":"van Horssen J, van Schaik P, Witte M (2017) Inflammation and mitochondrial dysfunction: a vicious circle in neurodegenerative disorders? Neurosci Lett"},{"key":"1678_CR65","first-page":"22","volume":"68","author":"Y Wu","year":"2011","unstructured":"Wu Y, Le W, Jankovic J (2011) Preclinical biomarkers of Parkinson disease. Arch Neurol 68:22\u201330","journal-title":"Arch Neurol"},{"key":"1678_CR66","doi-asserted-by":"crossref","first-page":"110743","DOI":"10.1016\/j.exger.2019.110743","volume":"128","author":"T Yan","year":"2019","unstructured":"Yan T, Sun Y, Gong G, Li Y, Fan K, Wu B, Bi K, Jia Y (2019) The neuroprotective effect of Schisandrol A on 6-OHDA-induced PD mice may be related to PI3K\/AKT and IKK\/IkappaBalpha\/NF-kappaB pathway. Exp Gerontol 128:110743","journal-title":"Exp Gerontol"},{"key":"1678_CR67","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1016\/j.bbrc.2012.04.021","volume":"421","author":"HA Zhang","year":"2012","unstructured":"Zhang HA, Gao M, Zhang L, Zhao Y, Shi L-l, Chen B-n, Wang Y-h, Wang S-b, Du G-H (2012) Salvianolic acid a protects human SH-SY5Y neuroblastoma cells against H 2 O 2-induced injury by increasing stress tolerance ability. Biochem Biophys Res Commun 421:479\u2013483","journal-title":"Biochem Biophys Res Commun"},{"key":"1678_CR68","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1186\/s12974-020-1712-0","volume":"17","author":"X Zhang","year":"2020","unstructured":"Zhang X, Zhu LB, He JH, Zhang HQ, Ji SY, Zhang CN, Hou NN, Huang CP, Zhu JH (2020) Paroxetine suppresses reactive microglia-mediated but not lipopolysaccharide-induced inflammatory responses in primary astrocytes. J Neuroinflammation 17:50","journal-title":"J Neuroinflammation"}],"container-title":["Journal of Molecular Neuroscience"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12031-020-01678-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12031-020-01678-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12031-020-01678-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,5]],"date-time":"2023-10-05T14:39:28Z","timestamp":1696516768000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12031-020-01678-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,8,13]]},"references-count":68,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2021,3]]}},"alternative-id":["1678"],"URL":"https:\/\/doi.org\/10.1007\/s12031-020-01678-6","relation":{},"ISSN":["0895-8696","1559-1166"],"issn-type":[{"value":"0895-8696","type":"print"},{"value":"1559-1166","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,8,13]]},"assertion":[{"value":"19 June 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 August 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 August 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with Ethical Standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interests"}}]}}